Glucagonlike peptide (GLP-1)

a gut hormone that slows gastric emptying and stimulates insulin secretion. Its use has been posited in treatment of Type 2 diabetes mellitus, perhaps administered by patch, inhaler, or buccal pellet formulation. SYN: glucagonlike insulinotropic peptide.

As scientists who evolve with technology we treat innovation as a way of life, a life we dedicate to improvement and advancement of Safety, Health and Environment.
© Copyright 2025 Chemwatch
Chemwatch
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.